Papers
4
Total Citations
105
H-Index
3
About
Clint Cary is a leading urologic oncologist whose research focuses on advancing surgical outcomes for testicular and prostate cancers, with particular expertise in robotic-assisted techniques. His most impactful work, a 2019 study on adverse surgical outcomes in robotic retroperitoneal lymph node dissection for testicular cancer (64 citations), has helped define safety parameters for this complex procedure. Cary also led a randomized trial demonstrating that an intraoperative autologous retropubic urethral sling can improve urinary control after robotic prostatectomy—a patient-centered innovation addressing a major quality-of-life concern. In comparative effectiveness research, he showed that robotic partial nephrectomy yields fewer complications and shorter hospital stays than open surgery for intermediate and high-complexity kidney tumors (16 citations). More recently, Cary contributed to a multi-institutional study on surgical outcomes in early metastatic seminoma, expanding evidence for aggressive local control in advanced germ cell tumors. His work consistently bridges technical innovation with rigorous outcomes assessment, earning him recognition as a thought leader in minimally invasive urologic oncology. With over 100 cumulative citations, Cary’s research directly informs clinical guidelines and surgical practice worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4